131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
about
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current statusNothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapyTargeted radiotherapy for neuroblastomaThe selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaIncorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy.A gene therapy/targeted radiotherapy strategy for radiation cell kill by.A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.Dosimetry study of [I-131] and [I-125]- meta-iodobenz guanidine in a simulating model for neuroblastoma metastasis.Modeling combined radiopharmaceutical therapy: a linear optimization framework.Multi-size spheroid formation using microfluidic funnels.Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine.
P2860
Q26826863-B7724A3B-22E7-4603-9569-4FA2B707DDBEQ33652433-0A26CBB5-44CB-48A9-8200-FB7F8D83D57CQ34543646-54C2F4CA-295F-43C4-98EF-E540E821D76AQ35257440-321326B6-BB59-494D-BC40-561A90672D9BQ35977687-766E826C-363A-4D81-8022-27A9807E0FBEQ36291813-A04D0415-F780-4191-A732-2874750036C4Q37078231-F8D8C1D6-3E69-411B-A5B2-B30AE02B1B9BQ38559192-18251B3C-32FF-497D-85C4-8766EEF22E74Q40705069-8178DF24-6FD7-4316-8BF2-D387D74F7F98Q40810551-EE483966-2AA4-4EF3-B245-0154C902C8F1Q40838775-D7F86B4A-8A57-4E99-B4A2-67724521D068Q41029352-240DCF36-2DA1-43FC-B0D7-A0323DFA7725Q43747302-8F013616-B357-48A2-83AB-F02D1F14C556Q46149964-FCDDA12E-714F-42CC-BBAA-D483B9518EA9Q47174692-27A2D2CD-2CF2-47C1-9032-3147348393ADQ53585874-7DAE8A0C-0C59-449A-BFCE-DA1B5376BA80
P2860
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
@en
type
label
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
@en
prefLabel
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
@en
P2093
P2860
P356
P1476
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1992.408
P407
P577
1992-12-01T00:00:00Z
P5875
P6179
1048841759